health

Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar

Vancouver, British Columbia–(BUSINESS WIRE)–Welfare Digital Sciences Inc. (“Welfare” or the “Company”) (NEO: MED) (OTC: KONEF) (FRA: SQ2), an evidence-based mental health company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapies, supported by clinical research, announces that Najla Guthrie, CEO of Wellbeing, will participate in the upcoming Psychedelic Medicine Association (PMA) Webinar on Thursday, January 26e at 5 p.m. Pacific, 8 p.m. Eastern.

Najla will participate in “Improving access to psychedelic drugs and therapies,” panel on January 26e at 5pm PST/8pm EST.

Members of the PMA can register here.

For more information about the webinar, or to schedule a one-on-one meeting with the wellness management team, please email Natalie Dolphin at ndolphin@wellbeingdigital.co.

ABOUT WELFARE DIGITAL SCIENCES

Wellbeing Digital Sciences Inc. is an evidence-based mental health company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapies, supported by clinical research. Its mission is supported by a network of North American clinics that provide advanced therapies and other types of treatments to patients, as well as a contract research organization that offers clinical trial services to drug development clients. For more information, visit wellnessdigital.co.

On behalf of:

Najla Guthrie

Director

WELFARE DIGITAL SCIENCES

Notice Regarding Forward-Looking Information:

This press release contains forward-looking statements, including but not limited to statements regarding the Company’s business, assets or investments, as well as other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations on which they are based will materialize. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that may cause the predictions, forecasts, projections and other forward-looking statements to be incorrect, which may lead to actual performance and results in future periods differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among others, the state of the economy in general and capital markets in particular, investor interest in the Company’s business and prospects.

The forward-looking statements in this press release are made as of the date of this press release. Except as required by law, the Company disclaims any intent and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. In addition, the Company assumes no obligation to comment on any third-party expectations or statements regarding the matters discussed above.

Previous post
Stomach germ symptoms – topic
Next post
Moussa Dembele sees Aston Villa set transfer plan as Celtic windfall dream reaches end game